Press Coverage

FDA Grants New Indication to Sleep-Disorder Drug Xywav

Article on new indication for drug to treat idiopathic hypersomnia in adults mentions potential for abuse highlighted in ISMP’s QuarterWatch report.

For the full text, visit Managed Healthcare Executive online.

More News

Since the 2021-2022 influenza (flu) vaccine became available in September, the Institute for Safe Medication Practices (ISMP) has received multiple reports of mix-ups. Some patients have consented to a flu vaccine but received one of the COVID-19 vaccines instead, while others have received the flue